Evidence map›Paper›PMID 42018262›Full record

ReviewSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026

Integrative oncology in clinical practice, research, and education: Middle-Eastern and global perspectives.

Eran Ben-Arye, Tido von Schoen-Angerer, Maryam Rassouli, Gülbeyaz Can, Mohamed Hablas, Suha Omran, Konstantina Stylianou, Malak Rita Hajji, Neil Arun Nijhawan, Ibtisam Ghrayeb and 10 more

Abstract readReview
In one paragraph

Review in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Eran Ben-AryeRuth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. eranben@technion.ac.il.
Tido von Schoen-AngererInternational Federation of Anthroposophic Medical Associations IVAA, Brussels, Belgium.
Maryam RassouliCancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Gülbeyaz CanFlorence Nightingale Nursing Faculty, Istanbul University - Cerrahpasa, Istanbul, Turkey.
Mohamed HablasPalliative Care Services, Gharbia Cancer Society, Tanta, Egypt.
Suha OmranFaculty of Nursing/WHO Collaborating Center, Jordan University of Science and Technology, Irbid, Jordan.
Konstantina StylianouGerman Oncology Center, Limassol, Cyprus.
Malak Rita HajjiONCORAD Healthcare Group, Casablanca, Morocco.
Neil Arun NijhawanBurjeel Medical City, Abu Dhabi, UAE.
Ibtisam GhrayebMakassed Hospital, East Jerusalem, Palestine.
Nahla GaferPalliative Care Unit, Khartoum Oncology Hospital, Khartoum, Sudan.
Georg SeifertCharité Competence Center for Traditional and Integrative Medicine (CCCTIM), Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Jianping LiuCentre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Alain ToledanoRafael Institute, Integrative Medicine Center, Levallois-Perret, Paris, France.
Massimo BonucciIntegrative Oncology Project, Department Oncology, S. Andrea University Hospital, Rome, Italy.
Ricardo GhelmanBrazilian Academic Consortium for Integrative Health, CABSIN, Rio de Janeiro, Brazil.
Nina Fuller-ShavelBritish Society for Integrative Oncology (BSIO), Midhurst, UK.
Rammanohar PuthiyedathAmrita School of Ayurveda, Amrita Vishwa Vidyapeetham, Amritapuri, India.
Noah SamuelsCenter for Integrative Complementary Medicine, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Lorenzo CohenDepartment of Palliative, Rehabilitation, & Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to explore integrative oncology (IO) across the Middle East, examine how international IO leaders promote IO in the Middle East, and assess how the Middle East contributes to the development of IO globally. This narrative review employed a structured literature search and descriptive analytic approach, using multiple databases, predefined keywords, varied study designs, and multilingual sources. It was conducted by a multi-disciplinary team of clinicians, researchers, and medical educators from ten Middle Eastern countries (Cyprus, Egypt, Iran, Israel, Jordan, Morocco, Palestine, Sudan, Turkey, and United Arab Emirates) and global IO/palliative leaders from South America, India, China, Europe, and the USA, providing a real-life implementation perspective. The collaborative IO model of care ensures safe and effective traditional and herbal medicine practices, with a culturally-sensitive approach respecting health beliefs. Middle Eastern and international IO participants discuss how they can benefit from each other, drawing from Middle-East Research Group in Integrative Oncology (MERGIO) activities in clinical practice, research, and medical education. Important themes derived from the review include the potential for IO to advance patient-centered care, effectively improve quality of life-related concerns, ensure a safe therapeutic environment, and overcome accessibility- and disparity-related barriers. IO treatments should be provided by trained multi-disciplinary teams of integrative physicians and practitioners, within culturally-adapted multi-modal programs and a receptive national and regional healthcare policy. Research utilizing pragmatic methodologies reflects real-world IO practice, with IO prioritized in medical education providing students and healthcare professionals with high-quality clinical and research training across the Middle East.

Indexed as

Integrative OncologyNeoplasmsBiomedical ResearchEducation, MedicalHumansMiddle EastMiddle Eastern PeopleIntegrative oncologyMiddle-EastPalliative careSupportive cancer careTraditional Arab Islamic medicineTraditional medicine

Identifiers

PMID42018262
PMCPMC13102902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.